BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gruntz K, Bloechliger M, Becker C, Jick SS, Fuhr P, Meier CR, Rüegg S. Parkinson disease and the risk of epileptic seizures: PD and Epileptic Seizures. Ann Neurol 2018;83:363-74. [DOI: 10.1002/ana.25157] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Jacob L, Bohlken J, Schmitz B, Kostev K. Incidence of epilepsy and associated factors in elderly patients in Germany. Epilepsy Behav 2019;90:107-11. [PMID: 30529258 DOI: 10.1016/j.yebeh.2018.10.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
2 Foliaki ST, Schwarz B, Groveman BR, Walters RO, Ferreira NC, Orrù CD, Smith A, Wood A, Schmit OM, Freitag P, Yuan J, Zou W, Bosio CM, Carroll JA, Haigh CL. Neuronal excitatory-to-inhibitory balance is altered in cerebral organoid models of genetic neurological diseases. Mol Brain 2021;14:156. [PMID: 34635127 DOI: 10.1186/s13041-021-00864-w] [Reference Citation Analysis]
3 Cano A, Fonseca E, Ettcheto M, Sánchez-López E, de Rojas I, Alonso-Lana S, Morató X, Souto EB, Toledo M, Boada M, Marquié M, Ruíz A. Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways. Pharmaceuticals (Basel) 2021;14:1057. [PMID: 34681281 DOI: 10.3390/ph14101057] [Reference Citation Analysis]
4 Scorza FA, de Almeida AG, Fiorini AC, Scorza CA, Finsterer J. Parkinson's disease, epileptic seizures, and sudden death: Three faces of the same coin. Epilepsy & Behavior 2018;83:239-41. [DOI: 10.1016/j.yebeh.2018.03.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Drenthen GS, Backes WH, Aldenkamp AP, Vermeulen RJ, Klinkenberg S, Jansen JF. On the merits of non-invasive myelin imaging in epilepsy, a literature review. Journal of Neuroscience Methods 2020;338:108687. [DOI: 10.1016/j.jneumeth.2020.108687] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
6 Löscher W, Klein P. New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal? Pharmacol Ther 2021;:107934. [PMID: 34216705 DOI: 10.1016/j.pharmthera.2021.107934] [Reference Citation Analysis]
7 Rodrigo LM, Nyholt DR. Imputation and Reanalysis of ExomeChip Data Identifies Novel, Conditional and Joint Genetic Effects on Parkinson's Disease Risk. Genes (Basel) 2021;12:689. [PMID: 34064523 DOI: 10.3390/genes12050689] [Reference Citation Analysis]
8 Vöglein J, Kostova I, Arzberger T, Noachtar S, Dieterich M, Herms J, Schmitz P, Ruf V, Windl O, Roeber S, Simons M, Höglinger GU, Danek A, Giese A, Levin J. Seizure prevalence in neurodegenerative diseases-a study of autopsy proven cases. Eur J Neurol 2021. [PMID: 34472165 DOI: 10.1111/ene.15089] [Reference Citation Analysis]
9 Uytterhoeven V, Kaempf N, Verstreken P. Mitochondria Re-set Epilepsy. Neuron 2019;102:907-10. [PMID: 31170397 DOI: 10.1016/j.neuron.2019.05.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Freitas ME, Ruiz-lopez M, Dalmau J, Erro R, Privitera M, Andrade D, Fasano A. Seizures and movement disorders: phenomenology, diagnostic challenges and therapeutic approaches. J Neurol Neurosurg Psychiatry 2019;90:920-8. [DOI: 10.1136/jnnp-2018-320039] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
11 Srivastava A, Kumar K, Banerjee J, Tripathi M, Dubey V, Sharma D, Yadav N, Sharma MC, Lalwani S, Doddamani R, Chandra PS, Dixit AB. Transcriptomic profiling of high- and low-spiking regions reveals novel epileptogenic mechanisms in focal cortical dysplasia type II patients. Mol Brain 2021;14:120. [PMID: 34301297 DOI: 10.1186/s13041-021-00832-4] [Reference Citation Analysis]
12 Heilbron K, Noyce AJ, Fontanillas P, Alipanahi B, Nalls MA, Cannon P; 23andMe Research Team. The Parkinson's phenome-traits associated with Parkinson's disease in a broadly phenotyped cohort. NPJ Parkinsons Dis 2019;5:4. [PMID: 30937360 DOI: 10.1038/s41531-019-0077-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
13 Pflüger P, Pereira P, Loza MI, Brea J, Viña D, Kumar A, Fontenla JA. Gamma-decanolactone: Preliminary evaluation as potential antiparkinsonian drug. Eur J Pharmacol 2021;906:174276. [PMID: 34174267 DOI: 10.1016/j.ejphar.2021.174276] [Reference Citation Analysis]
14 Oonk NGM, Movig KLL, van der Palen J, Nijmeijer HW, van Kesteren ME, Dorresteijn LDA. The Impact of Non-dopaminergic Medication on Quality of Life in Parkinson's Disease. Clin Drug Investig 2021;41:809-16. [PMID: 34374959 DOI: 10.1007/s40261-021-01064-z] [Reference Citation Analysis]
15 Bacellar A, Assis TR, Pedreira BB, CÔrtes L, Santana S, Nascimento OJMD. Predictors of long length of hospital stay among elders admitted with seizures in a tertiary centre: a prospective study. Arq Neuropsiquiatr 2020;78:687-94. [PMID: 33263637 DOI: 10.1590/0004-282X20200062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Fu CH, Iascone DM, Petrof I, Hazra A, Zhang X, Pyfer MS, Tosi U, Corbett BF, Cai J, Lee J, Park J, Iacovitti L, Scharfman HE, Enikolopov G, Chin J. Early Seizure Activity Accelerates Depletion of Hippocampal Neural Stem Cells and Impairs Spatial Discrimination in an Alzheimer's Disease Model. Cell Rep 2019;27:3741-3751.e4. [PMID: 31242408 DOI: 10.1016/j.celrep.2019.05.101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
17 Vossel K, Karageorgiou E. Editorial: Silent Seizures and Memory Loss in Alzheimer's Disease. Front Neurol 2021;12:648650. [PMID: 33763022 DOI: 10.3389/fneur.2021.648650] [Reference Citation Analysis]
18 Blank LJ, Acton EK, Thibault D, Willis AW. Neurodegenerative disease is associated with increased incidence of epilepsy: a population based study of older adults. Age Ageing 2021;50:205-12. [PMID: 33030514 DOI: 10.1093/ageing/afaa194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Chaudhuri P, Prajapati KP, Anand BG, Dubey K, Kar K. Amyloid cross-seeding raises new dimensions to understanding of amyloidogenesis mechanism. Ageing Res Rev 2019;56:100937. [PMID: 31430565 DOI: 10.1016/j.arr.2019.100937] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
20 Wang X, Loi SM, Foster E, Chen Z, Velakoulis D, Kwan P. Predictors of New-Onset Epilepsy in People With Younger-Onset Neurocognitive Disorders. Front Aging Neurosci 2021;13:637260. [PMID: 33815091 DOI: 10.3389/fnagi.2021.637260] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Zelano J, Brigo F, Garcia‐patek S. Increased risk of epilepsy in patients registered in the Swedish Dementia Registry. Eur J Neurol 2019;27:129-35. [DOI: 10.1111/ene.14043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]